Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic

Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenc...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental research and public health 2021-03, Vol.18 (6), p.3234
Main Authors: Sánchez-García, Juan Carlos, Cortés-Martín, Jonathan, Rodríguez-Blanque, Raquel, Marín-Jiménez, Ana Eugenia, Montiel-Troya, Maria, Díaz-Rodríguez, Lourdes
Format: Article
Language:English
Subjects:
Anxiety - epidemiology
Anxiety disorders
Anxiety Disorders - epidemiology
Coronaviruses
COVID-19
Cross-Sectional Studies
Data collection
Depression - epidemiology
Disease
Diseases
Humans
Mental depression
Mental disorders
Mental Health
Pandemics
Patients
Population studies
Quality of life
Questionnaires
Rare diseases
Rare Diseases - epidemiology
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Surveys and Questionnaires
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenced the lives of patients with rare diseases regarding depression and anxiety. This Spanish study considered a heterogeneous population sample of 86 patients with confirmed diagnosis of different rare diseases. Participants took part in a cross-sectional online study by completing specific questionnaires on the study topic. Depression was measured using the Patient Health Questionnaire (PHQ-9), and the General Anxiety Disorder Scale (GAD-7) was used for evaluating anxiety. Data collection through an online questionnaire allowed for a greater population scope and therefore the inclusion patients of other nationalities in the study sample. Finally, as a general result, this study found that, in the face of the pandemic, anxiety and depression remained at a higher level in this group than in the general population, making these patients a vulnerable population group.
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph18063234